Literature DB >> 9298330

Influences on adolescent substance dependence: conduct disorder, depression, attention deficit hyperactivity disorder, and gender.

E A Whitmore1, S K Mikulich, L L Thompson, P D Riggs, G A Aarons, T J Crowley.   

Abstract

OBJECTIVE: In adolescents, conduct disorder (CD), attention deficit hyperactivity disorder (ADHD), and depression are frequently comorbid with substance dependence (SD). We hypothesized that the prevalence and severity of CD, major depressive disorder (MDD), and ADHD would differ by gender, and that these conditions would associate differentially with severity of SD in males and females.
METHODS: We examined these issues, using standardized diagnostic interviews, in 285 male and 82 female adolescents referred for comorbid CD and SD.
RESULTS: Males and females did not differ significantly in severity of substance involvement, MDD, or ADHD, but males had more severe CD. MDD severity was the only variable significantly associated with SD severity for females, while for males, severity of CD combined with MDD and ADHD was significantly associated with SD severity.
CONCLUSIONS: Among referred adolescents, CD, MDD, and ADHD may all be important concomitants of SD in males, while in females, depression may be the primary variable related to SD.

Entities:  

Mesh:

Year:  1997        PMID: 9298330     DOI: 10.1016/s0376-8716(97)00074-4

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  42 in total

Review 1.  Substance abuse treatment for high-risk adolescents.

Authors:  R E Booth; C F Kwiatkowski
Journal:  Curr Psychiatry Rep       Date:  1999-12       Impact factor: 5.285

Review 2.  Substance abuse in children and adolescents.

Authors:  B M Tripathi; R Lal
Journal:  Indian J Pediatr       Date:  1999 Jul-Aug       Impact factor: 1.967

Review 3.  Continuation and maintenance therapy of early-onset major depressive disorder.

Authors:  Graham J Emslie; Taryn L Mayes; Maryse Ruberu
Journal:  Paediatr Drugs       Date:  2005       Impact factor: 3.022

4.  Prevalence and comorbidity of major internalizing and externalizing problems among adolescents and adults presenting to substance abuse treatment.

Authors:  Ya-Fen Chan; Michael L Dennis; Rodney R Funk
Journal:  J Subst Abuse Treat       Date:  2007-06-15

5.  Utilization of mental health services among adolescents in community-based substance abuse outpatient clinics.

Authors:  Ya-Fen Chan; Mark D Godley; Susan H Godley; Michael L Dennis
Journal:  J Behav Health Serv Res       Date:  2007-12-21       Impact factor: 1.505

6.  Does conduct disorder mediate the development of substance use disorders in adolescents with bipolar disorder? A case-control family study.

Authors:  Timothy E Wilens; MaryKate Martelon; Markus J P Kruesi; Tiffany Parcell; Diana Westerberg; Mary Schillinger; Martin Gignac; Joseph Biederman
Journal:  J Clin Psychiatry       Date:  2009-02-10       Impact factor: 4.384

7.  Social and generalized anxiety symptoms and alcohol and cigarette use in early adolescence: the moderating role of perceived peer norms.

Authors:  Jennifer M Zehe; Craig R Colder; Jennifer P Read; William F Wieczorek; Liliana J Lengua
Journal:  Addict Behav       Date:  2012-12-13       Impact factor: 3.913

8.  12-step participation and outcomes over 7 years among adolescent substance use patients with and without psychiatric comorbidity.

Authors:  Felicia W Chi; Stacy Sterling; Cynthia I Campbell; Constance Weisner
Journal:  Subst Abus       Date:  2013       Impact factor: 3.716

Review 9.  The scientific foundation for understanding attention-deficit/hyperactivity disorder as a valid psychiatric disorder.

Authors:  Stephen V Faraone
Journal:  Eur Child Adolesc Psychiatry       Date:  2005-02       Impact factor: 4.785

10.  Parsing the familiality of oppositional defiant disorder from that of conduct disorder: a familial risk analysis.

Authors:  Carter R Petty; Michael C Monuteaux; Eric Mick; Samantha Hughes; Jacqueline Small; Stephen V Faraone; Joseph Biederman
Journal:  J Psychiatr Res       Date:  2008-05-01       Impact factor: 4.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.